Public Health
FDA AI Recalls: 6.3% Signals Post-Market Surveillance Gaps
The burgeoning field of healthcare AI promises transformative advancements, yet a critical analysis of post-market surveillance…
Public Health
Public Health
AI Health Regulation: Compliance Calendar for Investors
The landscape for artificial intelligence in healthcare is shifting dramatically, moving from a frontier of innovation…
Public Health
AdvaMed’s AI Gamble: Can Self-Regulation De-Risk Investment?
The rapid evolution of artificial intelligence in healthcare presents a critical juncture for regulatory oversight. As…
Medical Breakthroughs
AI Governance Platforms: De-Risking Healthcare Investments
The burgeoning field of AI in healthcare presents an unparalleled opportunity for innovation, yet it simultaneously…
Public Health
UnitedHealth AI Lawsuit: De-Risking AI Health Investment & Reimbursement
The ongoing class-action lawsuit against UnitedHealth Group for its alleged use of an AI algorithm to…
Public Health
Cardiac AI: How State Privacy Laws De-Risk Investments
The landscape of healthcare AI privacy is undergoing a rapid, state-driven transformation, presenting both opportunities and…
Public Health
EU AI Act: US Healthcare AI’s Billion Dollar Compliance Challenge
The clock is ticking for US healthcare AI companies eyeing the lucrative European market. With the…
Public Health
HL7 AI Office: De-Risking Cardiac AI Investment Through Standards
The rapid evolution of artificial intelligence in healthcare presents a dual challenge: harnessing its transformative potential…
Public Health
AI Governance Gold Rush: Vanta, Drata, OneTrust Eye Healthcare
The burgeoning landscape of AI in healthcare presents a dual challenge and opportunity for compliance. As…